These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 13801953)

  • 1. [Experiences with transaminase determination in subchronic and chronic lesions of the liver parenchyma].
    BOECKER W; HEINRICH WD
    Med Klin; 1960 Jul; 55():1229-33. PubMed ID: 13801953
    [No Abstract]   [Full Text] [Related]  

  • 2. [The practical value of serum transaminase determinations in diseases of the liver and bile ducts].
    LINDNER H
    Dtsch Med J; 1961 Jan; 12():15-23 contd. PubMed ID: 13762383
    [No Abstract]   [Full Text] [Related]  

  • 3. [The practical value of serum transaminase determinations in diseases of the liver and bile ducts].
    LINDNER HL
    Dtsch Med J; 1961 Jan; 12():33-9 concl. PubMed ID: 13762384
    [No Abstract]   [Full Text] [Related]  

  • 4. Diagnostic value of serum-transaminase activity in hepatic and gastrointestinal diseases.
    PRYSE-DAVIES J; WILKINSON JH
    Lancet; 1958 Jun; 1(7033):1249-53. PubMed ID: 13550981
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparative studies on the clinical value of serum quinineoxidase, transaminase and sorbitoldehydrogenase determination for the demonstration of liver damage in biliary calculosis.
    Genov D; Milev M
    Nauchni Tr Vissh Med Inst Sofiia; 1969; 48(2):7-12. PubMed ID: 4245256
    [No Abstract]   [Full Text] [Related]  

  • 6. [Value of the determination of serum glutamic-oxalacetic transaminase and serum glutamic-pyruvic transaminase in the diagnosis of myocardial infarct and liver disease].
    BOSTANCI N; BIYAL F
    Turk Tip Cemiy Mecm; 1959 Sep; 25():444-54. PubMed ID: 13803091
    [No Abstract]   [Full Text] [Related]  

  • 7. [Contribution to the study of serum transaminases and aldolases in liver diseases. Comparative bioptico-humoral investigations].
    LENZI G; TUCCI G; LODI A; LENZI E; FACCHINI G
    Bull Sci Med (Bologna); 1960; 132():433-68. PubMed ID: 13760890
    [No Abstract]   [Full Text] [Related]  

  • 8. [Repeated detection of increased transaminases].
    Baumgarten R; Nilius R
    Z Arztl Fortbild (Jena); 1991 Apr; 85(7):291-2. PubMed ID: 2063590
    [No Abstract]   [Full Text] [Related]  

  • 9. [Comparative value of enzyme changes and the methionine-S35 and Se-75 test in the diagnosis and prognosis of chronic liver diseases].
    Gligore V; Duţu A; Frăţilă I; Mosora N; Giurgiu A; Tecuceanu R
    Med Interna (Bucur); 1970 Apr; 22(4):403-8. PubMed ID: 5419086
    [No Abstract]   [Full Text] [Related]  

  • 10. [Transaminase activities in the diagnosis of hepatic diseases].
    SOARES CS
    J Med (Oporto); 1962 May; 48():5-28. PubMed ID: 13914660
    [No Abstract]   [Full Text] [Related]  

  • 11. [Significance of transaminase screening of blood donors in the determination of the carrier state of the non-A non-B virus and the diagnosis of chronic liver diseases].
    Mikola I; Nika M; Pusztai E
    Orv Hetil; 1987 Dec; 128(49):2581-5. PubMed ID: 3125505
    [No Abstract]   [Full Text] [Related]  

  • 12. [Not Available].
    Erni S; Beise U
    Praxis (Bern 1994); 2016 Jul; 105(15):909-13. PubMed ID: 27463278
    [No Abstract]   [Full Text] [Related]  

  • 13. A practical approach to the child with abnormal liver tests.
    Lamireau T; McLin V; Nobili V; Vajro P
    Clin Res Hepatol Gastroenterol; 2014 Jun; 38(3):259-62. PubMed ID: 24736033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of abnormal liver-enzyme results in asymptomatic patients.
    Pratt DS; Kaplan MM
    N Engl J Med; 2000 Apr; 342(17):1266-71. PubMed ID: 10781624
    [No Abstract]   [Full Text] [Related]  

  • 15. Diagnosing liver disease in asymptomatic patients.
    Chatwin T
    JAAPA; 2001 Dec; 14(12):39-47. PubMed ID: 11824089
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical and laboratory correlation of the transaminase test, an analysis of 111 patients for a period of thirteen months.
    HAND AM; WILSON JW
    J La State Med Soc; 1960 May; 112():161-6. PubMed ID: 14399437
    [No Abstract]   [Full Text] [Related]  

  • 17. [Thioctic acid in experimental liver diseases caused by selenium. Behavior of the transaminase activity and histological picture. Note II].
    SQUADRITO G; CERUSO D; SACCA A
    Policlinico Med; 1959 Dec; 66():450-7. PubMed ID: 13854922
    [No Abstract]   [Full Text] [Related]  

  • 18. [Values and limitations of an epidemiological survey for the detection of chronic liver diseases].
    Dusi U; Avogaro P; Crepaldi G; Enzi G
    Minerva Med; 1968 Feb; 59(10):504-14. PubMed ID: 5642233
    [No Abstract]   [Full Text] [Related]  

  • 19. The limitations of conventional liver function tests.
    McIntyre N
    Semin Liver Dis; 1983 Nov; 3(4):265-74. PubMed ID: 6359422
    [No Abstract]   [Full Text] [Related]  

  • 20. [Diagnostic evaluation of percutaneous blind liver biopsy].
    Zivković R; Babić D; Radosević V; Vucemilo M
    Lijec Vjesn; 1974 Dec; 96(12):766-72. PubMed ID: 4456108
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.